Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells

[1]  J. Bartek,et al.  Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment , 2012, Cell cycle.

[2]  S. Ramaswamy,et al.  Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.

[3]  Jiri Bartek,et al.  Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth , 2012, The Journal of experimental medicine.

[4]  Guang-Yuh Chiou,et al.  Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis , 2012, Journal of cellular physiology.

[5]  K. Camphausen,et al.  The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells. , 2012, Neoplasia.

[6]  A. Ashworth,et al.  The DNA damage response and cancer therapy , 2012, Nature.

[7]  M. Kool,et al.  PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation , 2011, Oncotarget.

[8]  P. Mischel,et al.  Metabolic state of glioma stem cells and nontumorigenic cells , 2011, Proceedings of the National Academy of Sciences.

[9]  H. Immervoll,et al.  Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma , 2011, Acta Neuropathologica.

[10]  B. Telfer,et al.  Inhibition of PARP-1 by Olaparib (AZD2281) Increases the Radiosensitivity of a Lung Tumor Xenograft , 2011, Molecular Cancer Therapeutics.

[11]  J. Stamler,et al.  Glioma Stem Cell Proliferation and Tumor Growth Are Promoted by Nitric Oxide Synthase-2 , 2011, Cell.

[12]  Qiulian Wu,et al.  Elevated invasive potential of glioblastoma stem cells. , 2011, Biochemical and biophysical research communications.

[13]  Qiulian Wu,et al.  L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1 , 2011, The EMBO journal.

[14]  M. Toulmonde,et al.  A review of PARP inhibitors: from bench to bedside. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  A. Pyle,et al.  Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. , 2011, Cell stem cell.

[16]  M. Bjørås,et al.  Mitochondrial DNA Integrity Is Essential For Mitochondrial Maturation During Differentiation of Neural Stem Cells , 2010, Stem cells.

[17]  J. Bartek,et al.  Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas , 2010, Oncogene.

[18]  H. Wakimoto,et al.  Accumulation of CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation. , 2010, Journal of neurosurgery.

[19]  G. Bernier,et al.  BMI1 Confers Radioresistance to Normal and Cancerous Neural Stem Cells through Recruitment of the DNA Damage Response Machinery , 2010, The Journal of Neuroscience.

[20]  Alessia Pica,et al.  Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  L. Chin,et al.  Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy , 2010, PloS one.

[22]  R. McLendon,et al.  Integrin alpha 6 regulates glioblastoma stem cells. , 2010, Cell stem cell.

[23]  W. McBride,et al.  Radiation Resistance of Cancer Stem Cells: The 4 R's of Radiobiology Revisited , 2010, Stem cells.

[24]  B. Sullenger,et al.  Notch Promotes Radioresistance of Glioma Stem Cells , 2009, Stem cells.

[25]  Jie Zhang,et al.  Head and neck cancer radiosensitization by the novel poly(ADP‐ribose) polymerase inhibitor GPI‐15427 , 2009, Head & neck.

[26]  Justin C. Grindley,et al.  Tumour-initiating cells: challenges and opportunities for anticancer drug discovery , 2009, Nature Reviews Drug Discovery.

[27]  Jung-Sik Kim,et al.  Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors , 2009, EMBO molecular medicine.

[28]  G. Smyth,et al.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.

[29]  Anthony J Chalmers,et al.  Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90 , 2009, Molecular Cancer Therapeutics.

[30]  Hui Wang,et al.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.

[31]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[32]  S. Chiou,et al.  Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression. , 2009, Biochemical and biophysical research communications.

[33]  K. Camphausen,et al.  In vitro and In vivo Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016 , 2009, Clinical Cancer Research.

[34]  A. Chalmers,et al.  Replication-dependent radiosensitization of human glioma cells by inhibition of poly(ADP-Ribose) polymerase: mechanisms and therapeutic potential. , 2008, International journal of radiation oncology, biology, physics.

[35]  J. Bartek,et al.  Regulation of Replication Fork Progression Through Histone Supply and Demand , 2007, Science.

[36]  David H. Johnson,et al.  Inhibition of Poly(ADP-Ribose) Polymerase Enhances Cell Death and Improves Tumor Growth Delay in Irradiated Lung Cancer Models , 2007, Clinical Cancer Research.

[37]  C. Leonetti,et al.  Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis. , 2007, European journal of cancer.

[38]  Eric F. Johnson,et al.  ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models , 2007, Clinical Cancer Research.

[39]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[40]  K. Black,et al.  Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.

[41]  Qiulian Wu,et al.  Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. , 2006, Cancer research.

[42]  M. Piris,et al.  Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis. , 2006, Cancer research.

[43]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[44]  Alan Ashworth,et al.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.

[45]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[46]  Ugo Orfanelli,et al.  Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.

[47]  B. Marples,et al.  PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation. , 2004, International journal of radiation oncology, biology, physics.

[48]  Robert Almassy,et al.  Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361. , 2004, Journal of the National Cancer Institute.

[49]  Daniel H. Geschwind,et al.  Cancerous stem cells can arise from pediatric brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[51]  D. Steindler,et al.  Human cortical glial tumors contain neural stem‐like cells expressing astroglial and neuronal markers in vitro , 2002, Glia.

[52]  T. Haaf,et al.  Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[53]  W. Greco,et al.  The search for synergy: a critical review from a response surface perspective. , 1995, Pharmacological reviews.

[54]  K. Tonkin,et al.  The effect of 3-aminobenzamide in the radiation response of three human cervix carcinoma xenografts. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[55]  C. I. Bliss.  THE TOXICITY OF POISONS APPLIED JOINTLY1 , 1939 .